Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 43.00
+1.90 (4.62%)
Aug 26, 2026, 1:52 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 8.24 billion as of August 25, 2026. Its market cap has increased by 17.43% in one year.
Market Cap
8.24B
Enterprise Value
8.16B
Revenue
19.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.00
ChartMarket Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 8.24B, a decrease of -16.57%. That is a compound annual growth rate of -4.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 8.24B | 43.33% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 9.97B |
| AP Biosciences | 9.84B |
| Tanvex BioPharma | 9.61B |
| PharmaEngine | 8.51B |
| Adimmune | 7.50B |
| Acepodia | 7.08B |
| Savior Lifetec | 6.71B |
| TWi Biotechnology | 6.54B |